Singaporean extradited to face US charges over global insider trading scheme


BOSTON, Nov 20 (Reuters) - A ⁠Singaporean man has been extradited to the US to face charges that he helped lead ⁠a global insider trading network that made tens of millions of dollars trading on ‌confidential information about the finances and merger plans of numerous companies.

Zhi Ge, 35, made his initial appearance in federal court in Boston on Friday after he was extradited from Singapore to face securities fraud and money laundering charges following his arrest ​in his home country in 2024, the US Department of ⁠Justice said.

He is one of nine individuals ⁠overall charged with participating in what prosecutors allege was a years-long insider trading scheme that relied ⁠on ‌tips from investment bankers and other corporate insiders.

Prosecutors say Ge led the scheme along with Samy Khouadja, a former investment banker in France, and Eamma Safi, who co-owned a French ⁠restaurant with Khouadja. The US considers most of the defendants, including ​Khouadja, fugitives.

A court in Singapore ‌recently ordered Ge extradited to the US. He is scheduled to appear in federal court ⁠again on December ​16 for an arraignment.

"He will plead not guilty and anticipates a vigorous defense," Kevin Barron, Ge's lawyer, said in an email.

A lawyer for Khouadja did not immediately respond to a request for comment. Safi, who has been ⁠in US custody since 2025, has pleaded not guilty.

Prosecutors allege ​Khouadja, Safi and Ge from 2016 to 2024 recruited bankers and others to supply them with inside information about a variety of publicly traded companies and paid insiders for their illicit tips.

Charging papers say Ge ⁠attempted to recruit additional insiders into the scheme and cite messages he sent in 2019 encouraging an actor friend in New York to introduce him to "investment bankers in big banks working in M&A specifically."

The indictment said tips allowed them to engage in insider trading ahead of announcements about various deals including ​AstraZeneca's 2020 planned $39 billion acquisition of Alexion Pharmaceuticals and Novartis's 2024 ⁠acquisition of MorphoSys for $2.9 billion.

Ge and others would also use "burner" cell phones and encrypted messaging apps to conceal ​their activity and would speak in code, referring to money ‌as "greens" and a company's prospective merger partners as "girls" and "models."

Prosecutors ​said the defendants also leaked information they obtained to journalists to make a trading profit once the news became public.

(Reporting by Nate Raymond in Boston; Editing by Sanjeev Miglani)

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Air Pollutant Index

Note: API is calculated based on 24hr running average of the most dominant parameter.

Highest API Readings

    Select State and Location to view the latest API reading

    Others Also Read